These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16702212)

  • 1. Structural basis for degenerate recognition of natural HIV peptide variants by cytotoxic lymphocytes.
    Martinez-Hackert E; Anikeeva N; Kalams SA; Walker BD; Hendrickson WA; Sykulev Y
    J Biol Chem; 2006 Jul; 281(29):20205-12. PubMed ID: 16702212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
    J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
    Kan-Mitchell J; Bajcz M; Schaubert KL; Price DA; Brenchley JM; Asher TE; Douek DC; Ng HL; Yang OO; Rinaldo CR; Benito JM; Bisikirska B; Hegde R; Marincola FM; Boggiano C; Wilson D; Abrams J; Blondelle SE; Wilson DB
    J Immunol; 2006 Jun; 176(11):6690-701. PubMed ID: 16709828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
    J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation.
    Goulder PJ; Pasquier C; Holmes EC; Liang B; Tang Y; Izopet J; Saune K; Rosenberg ES; Burchett SK; McIntosh K; Barnardo M; Bunce M; Walker BD; Brander C; Phillips RE
    Immunol Lett; 2001 Nov; 79(1-2):109-16. PubMed ID: 11595297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine-tuning of T-cell receptor avidity to increase HIV epitope variant recognition by cytotoxic T lymphocytes.
    Bennett MS; Joseph A; Ng HL; Goldstein H; Yang OO
    AIDS; 2010 Nov; 24(17):2619-28. PubMed ID: 20881472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
    López M; Soriano V; Lozano S; Martinez P; Sempere J; González-Lahoz J; Benito J
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):884-92. PubMed ID: 16989614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.
    Goulder PJ; Altfeld MA; Rosenberg ES; Nguyen T; Tang Y; Eldridge RL; Addo MM; He S; Mukherjee JS; Phillips MN; Bunce M; Kalams SA; Sekaly RP; Walker BD; Brander C
    J Exp Med; 2001 Jan; 193(2):181-94. PubMed ID: 11148222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residues outside of the HLA-A2 peptide-binding groove can abrogate or enhance recognition of influenza virus matrix peptide pulsed cells by cytotoxic T lymphocytes.
    Teng JM; Hogan KT
    Mol Immunol; 1994 Apr; 31(6):445-57. PubMed ID: 8183283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble HIV-specific T cell receptor: expression, purification and analysis of the specificity.
    Anikeeva N; Lebedeva T; Sumaroka M; Kalams SA; Sykulev Y
    J Immunol Methods; 2003 Jun; 277(1-2):75-86. PubMed ID: 12799041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and characterization of highly immunogenic and broadly recognized mimics of the HIV-1 CTL epitope Gag77-85.
    Boggiano C; Moya R; Pinilla C; Bihl F; Brander C; Sidney J; Sette A; Blondelle SE
    Eur J Immunol; 2005 May; 35(5):1428-37. PubMed ID: 15789356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
    McKinney DM; Skvoretz R; Livingston BD; Wilson CC; Anders M; Chesnut RW; Sette A; Essex M; Novitsky V; Newman MJ
    J Immunol; 2004 Aug; 173(3):1941-50. PubMed ID: 15265928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
    Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
    Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Reactivity Between Influenza Matrix- and HIV-1 P17-Specific CTL-A Large Cohort Study.
    Hückelhoven AG; Etschel JK; Bergmann S; Zitzelsberger K; Mueller-Schmucker SM; Harrer EG; Harrer T
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):528-35. PubMed ID: 25900164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
    Yang X; Chen G; Weng NP; Mariuzza RA
    J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.
    Yang OO; Kalams SA; Rosenzweig M; Trocha A; Jones N; Koziel M; Walker BD; Johnson RP
    J Virol; 1996 Sep; 70(9):5799-806. PubMed ID: 8709196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.